Advertisement

Dialyseshunts pp 125-135 | Cite as

Zentralvenöse Katheter zur Akut- und Dauerbehandlung

  • M. Hollenbeck
  • R. Schindler
Chapter

Zusammenfassung

Zentralvenöse Katheter sind als nichtgetunnelte zentralvenöse Dialysekatheter zur Akutdialyse und als getunnelte Katheter unverzichtbar. Immer häufiger werden sie im Rahmen der Dialyseeinleitung und als intermediärer oder dauerhafter Dialysezugang verwendet, obwohl sie im Vergleich zu nativen Shunts mit erheblichen Risiken (insbesondere der Infektgefährdung und der Induktion von zentralvenösen Stenosen) behaftet sind. Durch schonende Implantationstechniken (Venenpunktion unter sonographischer Kontrolle und Implantation über den Seldingerdraht unter Vermeidung von großlumigen und starren Schleusen), durch verbesserte Hygiene beim Anschluss an die Dialyse und durch moderne Lock-Lösungen lassen sich Komplikationsraten reduzieren.

Literatur

  1. Allon M (2003) Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution. Clin Infect Dis 36(12): 1539–1544CrossRefPubMedGoogle Scholar
  2. Allon M (2006) Prophylactic effect of antibiotic lock solution on bacteremia related to use of uncuffed hemodialysis catheters. Nat Clin Pract Nephrol 2(8): 418–419CrossRefPubMedGoogle Scholar
  3. Allon M, Daugirdas J, Depner TA et al (2006) Effect of change in vascular access on patient mortality in hemodialysis patients. Am J Kidney Dis 47(3): 469–477CrossRefPubMedGoogle Scholar
  4. Bambauer R, Inniger R, Pirrung KJ et al (1994) Complications and side effects associated with large-bore catheters in the subclavian and internal jugular veins. Artif Organs 18(4): 318–321CrossRefPubMedGoogle Scholar
  5. Beathard GA (2003) Integrated vascular access management. Blood Purif 21(1): 89–98CrossRefPubMedGoogle Scholar
  6. Beathard GA, Urbanes A (2008) Infection associated with tunneled hemodialysis catheters. Semin Dial 21(6): 528–538CrossRefPubMedGoogle Scholar
  7. Bonkain F, Racape J, Goncalvez I et al (2013) Prevention of tunneled cuffed hemodialysis catheter-related dysfunction and bacteremia by a neutral-valve closed-system connector: a single-center randomized controlled trial. Am J Kidney Dis 61(3): 459–465CrossRefPubMedGoogle Scholar
  8. Cimochowski GE, Worley E, Rutherford WE et al (1990) Superiority of the internal jugular over the subclavian access for temporary dialysis. Nephron 54(2): 154–161CrossRefPubMedGoogle Scholar
  9. Dogra GK, Herson H, Hutchison B et al (2002) Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J Am Soc Nephrol 13(8): 2133–2139CrossRefPubMedGoogle Scholar
  10. Droste JC, Jeraj HA, MacDonald A et al (2003) Stability and in vitro efficacy of antibiotic-heparin lock solutions potentially useful for treatment of central venous catheter-related sepsis. J Antimicrob Chemother 51(4): 849–855CrossRefPubMedGoogle Scholar
  11. Gorke A (2005) Microbial contamination of haemodialysis catheter connections. EDTNA ERCA J 31(2): 79–84CrossRefPubMedGoogle Scholar
  12. Haage P, Vorwerk D, Piroth W et al (1999) Treatment of hemodialysis-related central venous stenosis or occlusion: results of primary Wallstent placement and follow-up in 50 patients. Radiology 212(1): 175–180CrossRefPubMedGoogle Scholar
  13. Hemmelgarn BR, Moist LM, Lok CE et al (2011) Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator. The New England journal of medicine 364(4): 303–312CrossRefPubMedGoogle Scholar
  14. Hernandez D, Diaz F, Suria S et al (1993) Subclavian catheter-related infection is a major risk factor for the late development of subclavian vein stenosis. Nephrol Dial Transplant 8(3): 227–230PubMedGoogle Scholar
  15. Hind D, Calvert N, McWilliams R et al (2003) Ultrasonic locating devices for central venous cannulation: meta-analysis. BMJ 327(7411): 361CrossRefPubMedPubMedCentralGoogle Scholar
  16. Hollenbeck M, Mickely V, Brunkwall J et al (2009) Interdisziplinäre Empfehlungen deutscher Fachgesellschaften zum Gefäßzugang zur Hämodialyse. Nephrologe 4: 158–176CrossRefGoogle Scholar
  17. Khanna R, Twardowski ZJ (1996) Recommendations for treatment of exit-site pathology. Perit Dial Int 16 Suppl 3: S100–S104PubMedGoogle Scholar
  18. Landry DL, Braden GL, Gobeille SL et al (2010) Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis. Clinical journal of the American Society of Nephrology : CJASN 5(10): 1799–1804CrossRefPubMedPubMedCentralGoogle Scholar
  19. Mickley V (2001) Stent or bypass? Treatment results in benign central venous obstruction. Zentralbl Chir 126(6): 445–449CrossRefPubMedGoogle Scholar
  20. Noordzij M, Jager KJ, van der Veer SN et al (2014) Use of vascular access for haemodialysis in Europe: a report from the ERA-EDTA Registry. Nephrol Dial Transplant 29(10): 1956–1964CrossRefPubMedGoogle Scholar
  21. Pastan S, Soucie JM, McClellan WM (2002) Vascular access and increased risk of death among hemodialysis patients. Kidney Int 62(2): 620–626CrossRefPubMedGoogle Scholar
  22. Pisoni RL, Young EW, Dykstra DM et al (2002) Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int 61(1): 305–316CrossRefPubMedGoogle Scholar
  23. Power A, Duncan N, Singh SK et al (2009) Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial. Am J Kidney Dis 53(6): 1034–1041CrossRefPubMedGoogle Scholar
  24. Rabe C, Gramann T, Sons X et al (2002) Keeping central venous lines open: a prospective comparison of heparin, vitamin C and sodium chloride sealing solutions in medical patients. Intensive Care Med 28(8): 1172–1176CrossRefPubMedGoogle Scholar
  25. Ruesch S, Walder B, Tramer MR (2002) Complications of central venous catheters: internal jugular versus subclavian access–a systematic review. Crit Care Med 30(2): 454–460CrossRefPubMedGoogle Scholar
  26. Schilcher G, Scharnagl H, Horina JH et al (2012) Trisodium citrate induced protein precipitation in haemodialysis catheters might cause pulmonary embolism. Nephrol Dial Transplant 27(7): 2953–2957CrossRefPubMedGoogle Scholar
  27. Schwab SJ, Quarles LD, Middleton JP et al (1988) Hemodialysis-associated subclavian vein stenosis. Kidney Int 33(6): 1156–1159CrossRefPubMedGoogle Scholar
  28. Solomon LR, Cheesbrough JS, Ebah L et al (2010) A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis. Am J Kidney Dis 55(6): 1060–1068CrossRefPubMedGoogle Scholar
  29. Solomon LR, Cheesbrough JS, Bhargava R et al (2012) Observational study of need for thrombolytic therapy and incidence of bacteremia using taurolidine-citrate-heparin, taurolidine-citrate and heparin catheter locks in patients treated with hemodialysis. Semin Dial 25(2): 233–238CrossRefPubMedGoogle Scholar
  30. Spindler B (2004) Vascular access for hemodialysis: the connection for life. Pflege Z 57(2): 89–93PubMedGoogle Scholar
  31. Tordoir J, Canaud B, Haage P et al (2007) EBPG on Vascular Access. Nephrol Dial Transplant 22 Suppl 2: ii88–117PubMedGoogle Scholar
  32. Weijmer MC, Debets-Ossenkopp YJ, Van De Vondervoort FJ et al (2002) Superior antimicrobial activity of trisodium citrate over heparin for catheter locking. Nephrol Dial Transplant 17(12): 2189–2195CrossRefPubMedGoogle Scholar
  33. Weijmer MC, Vervloet MG, ter Wee PM (2004) Compared to tunnelled cuffed haemodialysis catheters, temporary untunnelled catheters are associated with more complications already within 2 weeks of use. Nephrol Dial Transplant 19(3): 670–677CrossRefPubMedGoogle Scholar
  34. Weijmer MC, van den Dorpel MA, Van de Ven PJ et al (2005) Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J Am Soc Nephrol 16(9): 2769–2777CrossRefPubMedGoogle Scholar
  35. Zhao Y, Li Z, Zhang L et al (2014) Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials. Am J Kidney Dis 63(3): 479–490CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland 2017

Authors and Affiliations

  1. 1.Knappschaftskrankenhaus Bottrop GmbHChefarzt Klinik für Innere Medizin II, Leitender Arzt KfH Nierenzentrum BottropBottropDeutschland
  2. 2.Nierenzentrum ZehlendorfBerlinDeutschland

Personalised recommendations